ZACCARDELLI DAVID (President and CEO) sold 2.5% of their position (400K shares) of VERONA PHARMA PLC on the open market
Open‑market sale worth $1.28M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/14/2024ACC: 0001104659-24-089644
DirectorOfficer· President and CEO
Since Jan 2021
-400K
Net shares
Net seller
$1.28M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
400K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−1.60K
Price / share
$3.13
Trade value
$5.01K
% of position
0.0%
8/12/2024
16.25M→16.25M
Ordinary Shares
Direct
Shares
−390.18K
Price / share
$3.20
Trade value
$1.25M
% of position
2.4%
8/13/2024
16.25M→15.86M
Ordinary Shares
Direct
Shares
−8.22K
Price / share
$3.25
Trade value
$26.70K
% of position
0.1%
8/13/2024
15.86M→15.85M
Total
Net shares
−400K
Net value
-$1.28M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/12/2024 | S · Sale | −1.60K | $3.13 | $5.01K | 0.0% | 16.25M | 16.25M |
| Ordinary Shares Direct | 8/13/2024 | S · Sale | −390.18K | $3.20 | $1.25M | 2.4% | 16.25M | 15.86M |
| Ordinary Shares Direct | 8/13/2024 | S · Sale | −8.22K | $3.25 | $26.70K | 0.1% | 15.86M | 15.85M |
| Total | −400K | -$1.28M | ||||||
Derivative Transactions0
No derivative transactions reported